Allergy to cats and dogs is extremely common and occurs in up to 25% of people with allergies. Cat allergies are twice as common as dog allergies. Cat allergens are produced in large amounts, particularly by male non-neutered cats. The allergens are partially under hormonal control. Cats produce a protein known as Fel d 1, which is allergenic to human beings when it is infected with bacteria or viruses. The infected protein is contained in a pet’s urine, saliva, and skin. The dead skin of pets known as dander is regularly sloughed off and replaced by new skin cells. The dander can flake off from a pet’s fur and become airborne. It can be carried on the clothing of people who have pets such as cats and dogs and then shed in public places. Therefore, pet allergens especially that of cats and dogs, are a component of house dust even in homes where cats and dogs have never lived.
A rise in the adoption of cats and dogs as pets in households is expected to drive the pet allergy treatment drugs market. According to data from Allergy, Asthma & Immunology Research 2018, allergies to dog and cats affected 10% to 20% of the global population with allergic rhinoconjunctivitis and allergic asthma. Moreover, the same research also stated that cat allergies are a growing public health concern as their rates are increasing across the globe.
The global pet allergy treatment drugs market can be segmented based on drug class, distribution channel, and region. Based on drug class, the global pet allergy treatment drugs market can be classified into antihistamines, decongestants, corticosteroid, and others. The antihistamines segment is projected to account for a significant share of the market in the near future. This is because antihistamines effectively bind to histamine molecules that are released during an allergy reaction. They reduce the effect of the histamine reaction, which is the main allergic reaction. In terms of distribution channel, the pet allergy treatment drugs market can be categorized into retail pharmacies, hospital pharmacies, and online pharmacies. The retail pharmacies segment dominates the market. The segment is expected to expand at a rapid pace during the forecast period. This is because a large number of patients prefer to buy products through retail channels due the availability of drugs that can be purchased over the counter without prescriptions.
In terms of region, the global pet allergy treatment drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017. The region is projected to account for a significant share of the global pet allergy treatment drugs market during the forecast period, owing to a high incidence of pet allergies. The Humane Society of the United States (HSUS) 2017 report stated that an estimated 15% of the U.S. population is allergic to cats and dogs. High awareness about the effects of pets allergy on health and increase in the presence of cats and dogs in homes in European countries are resulting in a higher incidence of pets allergies. This is projected to boot the pet allergy treatment drugs market in Europe in the next few years.
Major players operating in the global pet allergy treatment drugs market include Sunovion Pharmaceuticals Inc., Allergon AB, Allergan, HAL Allergy Group, Allergy Therapeutics, Teva Pharmaceutical, Meda Pharmaceuticals Inc., GlaxoSmithKline, and Sallergenes Greer.
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates are included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453